Compound Evidence File
#EC-2026-0060
ACE-031
Filed under Peptides. The bureau holds 239 laboratory returns for this compound from 104 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
104 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 10.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 19 May 2026 | 8 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 10.0 | 10.0 | 24 Mar 2026 | 2 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Mar 2026 | 8 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 5 Jan 2026 | 8 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Jan 2026 | 24 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Feb 2026 | 12 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 22 Mar 2026 | 26 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 10.0 | 10.0 | 2 Jun 2026 | 1 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Mar 2026 | 13 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 3 May 2026 | 8 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Mar 2026 | 11 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Feb 2026 | 26 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 10.0 | 10.0 | 10.0 | 22 Dec 2025 | 11 Mar 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 10.0 | 10.0 | 10.0 | 16 May 2026 | 19 Jul 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 10.0 | 10.0 | 10.0 | 9 Jun 2025 | 9 Jun 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 | 2 Apr 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 10.0 | 10.0 | 10.0 | 7 May 2025 | 7 May 2025 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Jan 2026 | 20 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 5 May 2026 | 12 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 9.9 | 13 Nov 2025 | 24 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 25 Mar 2026 | 25 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 14 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 3 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 15 Jul 2026 | 2 Aug 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 9.6 | 9.6 | 9.6 | 7 May 2025 | 7 May 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 9.4 | 9.4 | 9.4 | 20 Jun 2025 | 20 Jun 2025 |
| Bfflist AMOCASE #VI-2026-0678 | X | 1 | 9.3 | 9.3 | 9.3 | 3 Jun 2025 | 3 Jun 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 9.3 | 9.3 | 9.3 | 11 Jun 2025 | 11 Jun 2025 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 9.2 | 9.2 | 9.2 | 3 Jul 2025 | 3 Jul 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.9 | 8.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 8.9 | 8.9 | 8.9 | 2 Apr 2025 | 2 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.8 | 7.8 | 10.0 | 25 May 2026 | 25 May 2026 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 8.8 | 8.8 | 8.8 | 25 Apr 2025 | 25 Apr 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 2 | 8.7 | 8.4 | 9.0 | 16 Mar 2025 | 20 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 8.7 | 8.7 | 8.7 | 28 Mar 2025 | 28 Mar 2025 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.6 | 8.6 | 8.6 | 6 May 2025 | 6 May 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 | 21 May 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.5 | 6.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 8.4 | 8.4 | 8.4 | 13 Jun 2025 | 13 Jun 2025 |
| UtherCASE #VI-2026-0902 | X | 2 | 8.3 | 7.2 | 9.5 | 2 Jul 2025 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.2 | 6.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 8.2 | 8.2 | 8.2 | 17 Dec 2024 | 17 Dec 2024 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 9 | 7.9 | 4.5 | 10.0 | 8 Jul 2025 | 21 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 9 | 7.8 | 5.8 | 9.4 | 7 May 2025 | 21 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 2 | 7.8 | 6.8 | 8.8 | 2 Jul 2025 | 21 May 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 7.7 | 7.7 | 7.7 | 28 Mar 2025 | 28 Mar 2025 |
| NextechLabsCASE #VI-2026-0285 | X | 3 | 7.5 | 5.4 | 10.0 | 25 Apr 2025 | 21 May 2026 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 7.5 | 7.5 | 7.5 | 3 Jul 2025 | 3 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 7.4 | 6.8 | 8.0 | 24 May 2026 | 24 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 7.2 | 5.4 | 8.9 | 7 May 2025 | 23 May 2026 |
| PeptiSlimCASE #VI-2026-0557 | X | 2 | 7.2 | 5.8 | 8.5 | 7 May 2025 | 20 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 2 | 7.2 | 6.1 | 8.4 | 28 Mar 2025 | 21 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 | 25 Apr 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 | 13 Feb 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 2 | 7.0 | 5.9 | 8.1 | 21 May 2025 | 19 Jan 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 7.0 | 7.0 | 7.0 | 14 Jan 2025 | 14 Jan 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 9 | 6.9 | 4.5 | 7.8 | 28 Mar 2025 | 21 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 | 24 Apr 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 6.9 | 6.9 | 6.9 | 7 May 2025 | 7 May 2025 |
| HK PeptidesCASE #VI-2026-0140 | X | 14 | 6.8 | 4.3 | 8.7 | 14 Jan 2025 | 23 May 2026 |
| Reta-PeptideCASE #VI-2026-0756 | X | 4 | 6.8 | 4.3 | 8.2 | 25 Apr 2025 | 19 Jan 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 2 | 6.8 | 6.3 | 7.2 | 13 Jun 2025 | 21 May 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 3 | 6.7 | 6.4 | 7.1 | 3 Jul 2025 | 26 Jan 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 | 24 Apr 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 6.5 | 6.5 | 6.5 | 3 Jul 2025 | 3 Jul 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 | 8 Jul 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 5 | 6.3 | 4.6 | 7.6 | 13 Feb 2025 | 21 May 2026 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 6.3 | 6.3 | 6.3 | 21 May 2025 | 21 May 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 2 | 6.2 | 4.3 | 8.2 | 13 Jun 2025 | 17 May 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 | 25 Apr 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.1 | 6.1 | 6.1 | 21 May 2025 | 21 May 2025 |
| Zztai PeptideCASE #VI-2026-0192 | C | 3 | 5.7 | 4.2 | 7.7 | 13 Feb 2025 | 21 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 2 | 5.5 | 5.5 | 5.6 | 8 Jul 2025 | 25 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 5.5 | 5.5 | 5.5 | 3 Jul 2025 | 3 Jul 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 3 | 5.4 | 4.0 | 6.5 | 14 Jan 2025 | 21 May 2026 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 | 25 Apr 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 2 | 5.3 | 4.3 | 6.4 | 13 Feb 2025 | 21 May 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 3 | 5.2 | 4.1 | 7.2 | 3 Jul 2025 | 20 May 2026 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 5.2 | 5.2 | 5.2 | 21 May 2025 | 21 May 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 5.0 | 5.0 | 5.0 | 8 Jul 2025 | 8 Jul 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 4.8 | 4.8 | 4.9 | 3 Jul 2025 | 26 Jan 2026 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 4.8 | 4.8 | 4.8 | 13 Feb 2025 | 13 Feb 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 | 6 May 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 4.6 | 4.6 | 4.6 | 13 Feb 2025 | 13 Feb 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 4.6 | 4.6 | 4.6 | 28 Mar 2025 | 28 Mar 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 2 | 4.5 | 2.5 | 6.5 | 17 Dec 2024 | 19 Jan 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 4.5 | 4.5 | 4.5 | 16 Mar 2025 | 16 Mar 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 4.3 | 4.2 | 4.5 | 2 Apr 2025 | 24 May 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 4.3 | 4.3 | 4.3 | 3 Jul 2025 | 3 Jul 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 2 | 4.2 | 3.2 | 5.1 | 28 Mar 2025 | 23 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 4.1 | 4.1 | 4.1 | 9 Jun 2025 | 9 Jun 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.4 | 3.4 | 3.4 | 3 Jul 2025 | 3 Jul 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 2.2 | 2.0 | 2.4 | 2 Jul 2025 | 17 May 2026 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 2.1 | 2.1 | 2.1 | 28 Mar 2025 | 28 Mar 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 2.0 | 2.0 | 2.0 | 24 Apr 2025 | 24 Apr 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 1.5 | 1.5 | 1.5 | 20 Jun 2025 | 20 Jun 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.8 | 0.8 | 0.8 | 16 Mar 2025 | 16 Mar 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.4 | 0.4 | 0.4 | 2 Apr 2025 | 2 Apr 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.2 | 0.2 | 0.2 | 28 Mar 2025 | 28 Mar 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.1 | 0.1 | 0.1 | 21 May 2025 | 21 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 24 Apr 2025 | 24 Apr 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
Open any subject to view the batch-level evidence for ACE-031 alone.